News
)
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
- Clinical research
- Long-read
- Clinical
- DNA
- Whole genome
August 9 2024
)
Oxford Nanopore Technologies collaborates with Twist Bioscience to launch Pharmacogenomics Beta Programme and advance personalised medicine
- Clinical research
- Long-read
- Biopharma
May 22 2024
)
Oxford Nanopore Technologies and UMC Utrecht collaborate on 1,000 human genome sequencing project
- Clinical research
- Direct analysis
- Metagenomics
- Long-read
- PromethION
- Real-time
September 30 2024
)
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
- Clinical research
- Cancer research
October 19 2023
Interview: Parent-of-origin genome analysis presents the potential to improve future genetic testing
- Clinical research
- Cancer research
- Epigenetics
June 30 2023
Interview: Advancing long-read de novo genome assembly methods in clinical research
- Clinical research
- Human genomics
- Interview
October 14 2022
Blog: Resolving structural variants causing antithrombin deficiency
- Clinical research
- Human genomics
- Structural variation
- Variant calling
- Long-read
- PromethION
September 14 2020
Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?
- Clinical research
- Cancer research
- Structural variation
- MinION
- Flongle
- GridION
September 29 2020
)
Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development
- Clinical research
- Protein
- Long-read
- Direct analysis
September 12 2024
)
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies
- Clinical research
- Whole genome
- Long-read
- PromethION
November 14 2024